3rd New Product Planning Summit -

3rd New Product Planning Summit
December 12 - 13, 2018
Boston, MA

Understand how to navigate the changing regulatory landscape and effectively manage resources and timelines

Agenda – 3rd New Product Planning Summit



Day One

 Wednesday, December 12

8:45AM – 9:00AM

Chairperson’s Opening Remarks


Tony Russell, Senior Director, Product Strategy and Commercial Planning, THERAVANCE BIOPHARMA

9:00AM – 9:45AM

Begin With the End In Mind: Why Getting It Right From the Start Is the Most Important Step in the Ongoing Process of New Product Planning


Dr. Raymond Donninger, Vice President, Head of Global Analytics, PRESCIENT HEALTHCARE GROUP
Philip Vorhies, Vice President, Managing Director, PRESCIENT HEALTHCARE GROUP

9:45AM – 10:30AM

Interactive Group Discussion


Tony Russell, Senior Director, Product Strategy and Commercial Planning, THERAVANCE BIOPHARMA

10:30AM – 11:00AM

Networking Break


11:00AM – 11:45AM

Develop a Commercially and Clinically Viable Differentiation Strategy — Then Validating It 


Brad Payne, MBA, Partner, ARTISAN HEALTHCARE CONSULTING

11:45AM – 12:30PM

Target Product Profile (TPP) – Development and Evolution from Pre-Clinical to Product Approval


Vincent Fisher, Director, Commercial Planning - HIV, Gilead Sciences

12:30PM – 1:30PM

Luncheon


1:30PM – 2:15PM

Appropriate Value-Based Decisions Into Clinical Development


John Sears, Ph.D., MBA, Health Care Quality and Commercial Strategy Director, JOHNSON & JOHNSON

2:15PM – 3:00PM

Panel: When Do You Incorporate Market Access Considerations Into Product Commercialization?


John Sears, Ph.D., MBA, Health Care Quality and Commercial Strategy Director, JOHNSON & JOHNSON

3:00PM – 3:30PM

Networking Break


3:30PM – 4:15PM

Extend the Use of Previously Approved Entities: Strategic Implications and Development Options


Katie MacFarlane, Senior Vice President, Commercial Development, NAPO PHARMACEUTICALS

4:15PM – 5:00PM

The Intersection of Drugs and Digital: A Look Ahead and the Implications for New Product Planners


Timothy Moore, Senior Vice President, PROMIDIAN CONSULTING


Day Two

 Thursday, December 13

8:00AM – 8:45AM

Continental Breakfast


 

Early Commercial Planning

8:45AM – 9:00AM
Chairpersons’ Recap of Day One

Katja Wachtendonk, Worldwide Director New Products, NOVARTIS PHAEMACEUTICALS

9:00AM – 9:45AM
Create a Successful Therapeutic Disease Area Strategy

Katja Wachtendonk, Worldwide Director New Products, NOVARTIS PHAEMACEUTICALS

9:45AM – 10:30AM
How to Work Effectively With Research Teams in New Product Planning

Tony Russell, Senior Director, Product Strategy and Commercial Planning, THERAVANCE BIOPHARMA

10:30AM – 11:15AM
CMC Perspectives for Global Launch for Oral and Combination Drug Products

Abizer Harianawala, Ph.D., Senior Director, Product Development and Technical Operations, TARIS BIOMEDICAL

Late-Stage and Launch Planning

8:45AM – 9:00AM
Chairpersons’ Recap of Day One

Charles Pak, Vice President, New Product Planning, SYROS PHARMACEUTICALS

9:00AM – 9:45AM
Effectively Partner With Clinical, Regulatory, and Translational Colleagues to Prepare the Marketplace Ahead of a Launch

Charles Pak, Vice President, New Product Planning, SYROS PHARMACEUTICALS

9:45AM – 10:30AM
Develop, Launch, and Test a Go-to-Market Strategy Ahead of Your Product Launch

Elizabeth Presson, Patient Engagement and Digital Strategy Lead, OTICON MEDICAL, LLC

10:30AM – 11:15AM
Develop a “Glocal” Marketing Communications Strategy

If you are interested in leading this session, please contact David Finkel at dfinkel@exlevents.com.

 

11:15AM – 11:45AM

Networking Break


11:45AM – 12:30PM

Lessons From Emerging Biopharma Companies Commercializing Their First Asset


Bart Lombardi, Founder and Managing Director, CLARION HEALTHCARE

12:30PM – 1:30PM

Luncheon


2:15PM – 3:00PM

Panel: Strategic Considerations for the Successful Launch of a New Product in Ex-U.S. Regions


Abizer Harianawala, Ph.D., Senior Director, Product Development and Technical Operations, TARIS BIOMEDICAL
Elizabeth Presson, Patient Engagement and Digital Strategy Lead, OTICON MEDICAL, LLC

3:00PM – 3:15PM

Chairperson’s Closing Remarks


Tony Russell, Senior Director, Product Strategy and Commercial Planning, THERAVANCE BIOPHARMA


live chat software